Vietnam Pet Veterinary Diets Market Trends and Insights
Rising Diagnosis and Treatment of Chronic Pet Conditions
Vietnamese clinics are handling more chronic pet conditions, and that is strengthening the treatment base for the Vietnam pet veterinary diets market. Vietnamese clinics are handling more chronic pet conditions, strengthening the treatment base for the Vietnam pet veterinary diets market. A 2024 research paper published in Veterinary Integrative Sciences reported that 37.1% of dogs and cats examined in Ho Chi Minh City presented with urolithiasis., indicating significant clinical demand for urinary support nutrition. The International Renal Interest Society stated in 2025 that renal diets remain a first-line nutritional measure for chronic kidney disease management, which supports the durable use of kidney care formulations once diagnosis occurs. This is important because therapeutic feeding in kidney and urinary care is not a one-time purchase and typically spans longer treatment cycles. The result is that chronic disease management supports repeat demand in a way that ordinary premium pet food does not.Expanding Pet Humanization and Premium Nutrition Spending
Pet care spending in Vietnam is increasingly tied to health outcomes and not only to basic feeding. Vietnam News Service reported in 2025 that pet owners in Ho Chi Minh City were willing to spend more than VND 30 million on a single treatment episode, equal to USD 1,200, which shows the willingness of urban households to support clinically guided care. A Vietnamese news reported in 2026 stated that the broader Vietnamese pet food market is projected to reach USD 167.98 million, indicating that premium and health-oriented nutrition is gaining a wider base. Vietnam Plus, a local news publisher, also reported in 2024 that the country’s fertility rate fell to 1.91, a trend that supports a shift in discretionary spending among younger urban households toward pets and pet wellness. This matters to the Vietnam pet veterinary diets market because premium therapeutic feeding tends to scale first where pet attachment, health spending, and urban lifestyle patterns are already aligned.Limited Awareness of Veterinary Diets Outside Major Cities
The market remains heavily concentrated in major urban centers, which limits addressable demand outside them. Nong Nghiep Moi Truong reported in 2025 that Vietnam’s veterinary sector still faced a shortage of licensed personnel, which means diagnostic capability remains concentrated in stronger clinic markets. In many secondary or rural areas, pets are more likely to pass through informal care channels that do not systematically identify diet-linked chronic conditions. That reduces both owner awareness and clinician-led conversion into prescription feeding. As a result, the Vietnam pet veterinary diets market can expand nationally only if diagnostic and education capacity spreads beyond the current metro-led base.Other drivers and restraints analyzed in the detailed report include:
- Growing Veterinary Clinic and Hospital Access in Vietnam
- Better Availability Through E-Commerce and Specialist Pet Retail
- Higher Price Sensitivity Versus Standard Pet Food
Segment Analysis
Renal diets were the largest sub-product, with 24.0% of the Vietnam pet veterinary diets market share in 2025, reflecting the long treatment duration usually associated with kidney disease management. The International Renal Interest Society stated in 2025 that renal nutrition remains central to chronic kidney disease care, supporting stable repeat demand in this subcategory. Urinary tract disease, diabetes, and digestive sensitivity form the next important therapeutic demand layer because they are tied to chronic management rather than short-term feeding changes. Loan and Dao reported in Veterinary Integrative Sciences in 2024 that urolithiasis prevalence reached 37.1% among examined dogs and cats in Ho Chi Minh City, supporting a stronger demand for urinary diets in urban clinical settings. Oral care and derma diets remain smaller because they require a more developed mix of owner awareness, diagnosis, and sustained nutritional compliance.Obesity diets are the fastest-growing sub-product and are projected to expand at 10.8% CAGR during 2026-2031. Obesity is a major risk factor for diabetes mellitus in cats, and that relationship supports broader long-term demand for weight-management nutrition in the Vietnam pet veterinary diets market. This gives obesity diets a role that goes beyond a single niche because weight control can affect diabetes and joint-related feeding needs over time. The other veterinary diets category includes early-stage cardiac and hepatic formulations, and these remain smaller because their clinical use depends on deeper diagnostic capability. As urban clinic standards improve, these smaller therapeutic niches can widen without taking away the leadership position of renal diets in the near term.
Complete Report Scope:
- By Sub Product
- Diabetes
- Digestive Sensitivity
- Oral Care Diets
- Renal
- Urinary Tract Disease
- Obesity Diets
- Derma Diets
- Other Veterinary Diets
- By Pets
- Cats
- Dogs
- Other Pets
- By Distribution Channel
- Convenience Stores
- Online Channel
- Specialty Stores
- Supermarkets/Hypermarkets
- Other Channels
List of Companies Covered in this Report:
- Mars, Incorporated
- Nestlé S.A.
- Colgate-Palmolive Company (Hills Pet Nutrition)
- Virbac S.A.
- Farmina Pet Foods Holding B.V.
- Affinity Petcare, S.A.
- Dechra Pharmaceuticals Limited
- Monge and C. S.p.A.
- United Petfood Group N.V.
- VAFO Group a.s.
- Pet Like Co., Ltd.
- Perfect Companion Group Co., Ltd.
- DoggyMan H.A. Co., Ltd.
- Archer-Daniels-Midland Company
- Charoen Pokphand Group Company Limited
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Mars, Incorporated
- Nestlé S.A.
- Colgate-Palmolive Company (Hills Pet Nutrition)
- Virbac S.A.
- Farmina Pet Foods Holding B.V.
- Affinity Petcare, S.A.
- Dechra Pharmaceuticals Limited
- Monge and C. S.p.A.
- United Petfood Group N.V.
- VAFO Group a.s.
- Pet Like Co., Ltd.
- Perfect Companion Group Co., Ltd.
- DoggyMan H.A. Co., Ltd.
- Archer-Daniels-Midland Company
- Charoen Pokphand Group Company Limited

